W. M. de Souza, L. Buss, D. Candido, J. Carrera, Sabrina L Li, A. Zarebski, R. Pereira, C. A. Prete, A. A. de Souza-Santos, K. Parag, M. C. Belotti, M. Vincenti-González, J. Messina, Flavia Cristina da Silva Sales, P. S. Andrade, V. H. Nascimento, F. Ghilardi, L. Abade, B. Gutiérrez, M. Kraemer, C. K. V. Braga, R. Aguiar, N. Alexander, P. Mayaud, O. Brady, I. Marcilio, N. Gouveia, Guangdi Li, A. Tami, S. B. de Oliveira, V. B. Pôrto, F. Ganem, W. A. F. de Almeida, F. F. S. Fantinato, E. Macário, W. D. de Oliveira, M. Nogueira, O. Pybus, Chieh-Hsi Wu, J. Croda, E. Sabino, N. Faria
Nature Human Behaviour, 2020
The first case of COVID-19 was detected in Brazil on 25 February 2020. We report and contextualize epidemiological, demographic and clinical findings for COVID-19 cases during the first 3 months of the epidemic. By 31 May 2020, 514,200 COVID-19 cases, including 29,314 deaths, had been reported in 75.3% (4,196 of 5,570) of municipalities across all five administrative regions of Brazil. The R0 value for Brazil was estimated at 3.1 (95% Bayesian credible interval = 2.4–5.5), with a higher median but overlapping credible intervals compared with some other seriously affected countries. A positive association between higher per-capita income and COVID-19 diagnosis was identified. Furthermore, the severe acute respiratory infection cases with unknown aetiology were associated with lower per-capita income. Co-circulation of six respiratory viruses was detected but at very low levels. These findings provide a comprehensive description of the ongoing COVID-19 epidemic in Brazil and may help to guide subsequent measures to control virus transmission. Brazil has one of the fastest-growing COVID-19 epidemics in the world. De Souza et al. report epidemiological, demographic and clinical findings for COVID-19 cases in the country during the first 3 months of the epidemic.
Cited by 108 publications.
Field of study: Medicine